Cargando…

Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison

BACKGROUND: To compare patient survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) from live donors (LD) or extended criteria donors (ECD). METHODS: Data from consecutive LT procedures for HCC involving either LD or ECD were reviewed. Patient survival was our primary outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Sotiropoulos, Georgios C., Spartalis, Eleftherios, Machairas, Nikolaos, Paul, Andreas, Malagó, Massimo, Neuhäuser, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191876/
https://www.ncbi.nlm.nih.gov/pubmed/30386123
http://dx.doi.org/10.20524/aog.2018.0301
_version_ 1783363798199959552
author Sotiropoulos, Georgios C.
Spartalis, Eleftherios
Machairas, Nikolaos
Paul, Andreas
Malagó, Massimo
Neuhäuser, Markus
author_facet Sotiropoulos, Georgios C.
Spartalis, Eleftherios
Machairas, Nikolaos
Paul, Andreas
Malagó, Massimo
Neuhäuser, Markus
author_sort Sotiropoulos, Georgios C.
collection PubMed
description BACKGROUND: To compare patient survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) from live donors (LD) or extended criteria donors (ECD). METHODS: Data from consecutive LT procedures for HCC involving either LD or ECD were reviewed. Patient survival was our primary outcome. Re-transplantation (Re-LT), ischemic type bile lesions (ITBL), and tumor recurrence represented secondary outcomes. The primary outcome was statistically analyzed using Kaplan-Meier estimates and Cox proportional hazards regression; logistic regression analyses were used for statistical analysis of the secondary outcomes. Propensity score was calculated based on patient age, sex, hepatitis C viral infection (HCV), laboratory model for end-stage liver disease (labMELD) score, bridging treatment, Milan criteria, α-fetoprotein levels, and tumor grade. RESULTS: The study evaluated 109 recipients undergoing LT from either LD (n=57) or ECD (n=52). LT procedure (hazard ratio [HR] 2.349, 95% confidence interval [CI] 1.151-4.794, P=0.0190), age (HR 1.075, 95%CI 1.020-1.133, P=0.0074) and labMELD score (HR 1.082, 95%CI 1.021-1.147, P=0.0075) reached significance by Cox proportional hazards regression. After adjustment with the propensity score (stratification with 5 strata), the LT procedure was still significant (HR 2.401, 95%CI 1.114-5.175, P=0.0253). Tumor grade (odds ratio [OR] 9.628, 95%CI 1.120-82.752, P=0.0391), labMELD score (OR 1.224, 95%CI 1.019-1.471, P=0.0306), and Milan criteria (OR 6.375, 95%CI 1.239-32.796, P=0.0267) gained statistical significance by logistic regression analysis for Re-LT, ITBL, and tumor recurrence, respectively. CONCLUSIONS: LT for HCC showed superior patient survival with ECD rather than LD grafts. Re-LT, ITBL, and tumor recurrence showed no significant differences between the two groups. However, the diverging criteria for the definition of ECD grafts represent a considerable limitation for the wide application of this policy.
format Online
Article
Text
id pubmed-6191876
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hellenic Society of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-61918762018-11-01 Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison Sotiropoulos, Georgios C. Spartalis, Eleftherios Machairas, Nikolaos Paul, Andreas Malagó, Massimo Neuhäuser, Markus Ann Gastroenterol Original Article BACKGROUND: To compare patient survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) from live donors (LD) or extended criteria donors (ECD). METHODS: Data from consecutive LT procedures for HCC involving either LD or ECD were reviewed. Patient survival was our primary outcome. Re-transplantation (Re-LT), ischemic type bile lesions (ITBL), and tumor recurrence represented secondary outcomes. The primary outcome was statistically analyzed using Kaplan-Meier estimates and Cox proportional hazards regression; logistic regression analyses were used for statistical analysis of the secondary outcomes. Propensity score was calculated based on patient age, sex, hepatitis C viral infection (HCV), laboratory model for end-stage liver disease (labMELD) score, bridging treatment, Milan criteria, α-fetoprotein levels, and tumor grade. RESULTS: The study evaluated 109 recipients undergoing LT from either LD (n=57) or ECD (n=52). LT procedure (hazard ratio [HR] 2.349, 95% confidence interval [CI] 1.151-4.794, P=0.0190), age (HR 1.075, 95%CI 1.020-1.133, P=0.0074) and labMELD score (HR 1.082, 95%CI 1.021-1.147, P=0.0075) reached significance by Cox proportional hazards regression. After adjustment with the propensity score (stratification with 5 strata), the LT procedure was still significant (HR 2.401, 95%CI 1.114-5.175, P=0.0253). Tumor grade (odds ratio [OR] 9.628, 95%CI 1.120-82.752, P=0.0391), labMELD score (OR 1.224, 95%CI 1.019-1.471, P=0.0306), and Milan criteria (OR 6.375, 95%CI 1.239-32.796, P=0.0267) gained statistical significance by logistic regression analysis for Re-LT, ITBL, and tumor recurrence, respectively. CONCLUSIONS: LT for HCC showed superior patient survival with ECD rather than LD grafts. Re-LT, ITBL, and tumor recurrence showed no significant differences between the two groups. However, the diverging criteria for the definition of ECD grafts represent a considerable limitation for the wide application of this policy. Hellenic Society of Gastroenterology 2018 2018-07-27 /pmc/articles/PMC6191876/ /pubmed/30386123 http://dx.doi.org/10.20524/aog.2018.0301 Text en Copyright: © Hellenic Society of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sotiropoulos, Georgios C.
Spartalis, Eleftherios
Machairas, Nikolaos
Paul, Andreas
Malagó, Massimo
Neuhäuser, Markus
Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison
title Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison
title_full Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison
title_fullStr Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison
title_full_unstemmed Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison
title_short Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison
title_sort liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191876/
https://www.ncbi.nlm.nih.gov/pubmed/30386123
http://dx.doi.org/10.20524/aog.2018.0301
work_keys_str_mv AT sotiropoulosgeorgiosc livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison
AT spartaliseleftherios livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison
AT machairasnikolaos livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison
AT paulandreas livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison
AT malagomassimo livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison
AT neuhausermarkus livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison